Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro

M. K. Ki, M. H. Jeoung, J. R. Choi, S. S. Rho, Y. G. Kwon, H. Shim, J. Chung, H. J. Hong, B. D. Song, S. Lee

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

It has been suggested that clec14a may be involved in tumor angiogenesis. However, a molecular mechanism has not been clearly identified. In this study, we show for the first time that C-type lectin-like domain (CTLD) of clec14a may be important for regulating cell migration and filopodia formation. Using phage display technology, recombinant human antibodies specific to the CTLDs of human and mouse clec14a (clec14a-CTLD (immunoglobulin G) IgG) were selected. Functional assays using the antibodies showed that clec14a-CTLD IgGs specifically blocked endothelial cell migration and tube formation without affecting cell viability or activation. Further, clec14a-CTLD IgGs inhibited clec14a-mediated cell-cell contact by blocking interaction between CTLDs. Finally, clec14a cross-linking by the clec14a-CTLD IgGs significantly downregulated clec14a expression on the surface of endothelial cells. These results strongly suggest that the clec14a-CTLD may be a key domain in angiogenesis, and that clec14a-CTLD IgGs specifically inhibit angiogenesis by modulating CTLD-mediated cell interactions and clec14a expression on the surface of endothelial cells.

Original languageEnglish
Pages (from-to)5449-5457
Number of pages9
JournalOncogene
Volume32
Issue number48
DOIs
Publication statusPublished - 2013 Nov 28

Fingerprint

C-Type Lectins
Endothelial Cells
Antibodies
Neoplasms
Cell Movement
Immunoglobulin G
Pseudopodia
In Vitro Techniques
Cell Communication
Bacteriophages
Cell Survival
Down-Regulation
Technology

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Ki, M. K. ; Jeoung, M. H. ; Choi, J. R. ; Rho, S. S. ; Kwon, Y. G. ; Shim, H. ; Chung, J. ; Hong, H. J. ; Song, B. D. ; Lee, S. / Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro. In: Oncogene. 2013 ; Vol. 32, No. 48. pp. 5449-5457.
@article{c928d6f4a9b04f9c95ca95cda8ae72b5,
title = "Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro",
abstract = "It has been suggested that clec14a may be involved in tumor angiogenesis. However, a molecular mechanism has not been clearly identified. In this study, we show for the first time that C-type lectin-like domain (CTLD) of clec14a may be important for regulating cell migration and filopodia formation. Using phage display technology, recombinant human antibodies specific to the CTLDs of human and mouse clec14a (clec14a-CTLD (immunoglobulin G) IgG) were selected. Functional assays using the antibodies showed that clec14a-CTLD IgGs specifically blocked endothelial cell migration and tube formation without affecting cell viability or activation. Further, clec14a-CTLD IgGs inhibited clec14a-mediated cell-cell contact by blocking interaction between CTLDs. Finally, clec14a cross-linking by the clec14a-CTLD IgGs significantly downregulated clec14a expression on the surface of endothelial cells. These results strongly suggest that the clec14a-CTLD may be a key domain in angiogenesis, and that clec14a-CTLD IgGs specifically inhibit angiogenesis by modulating CTLD-mediated cell interactions and clec14a expression on the surface of endothelial cells.",
author = "Ki, {M. K.} and Jeoung, {M. H.} and Choi, {J. R.} and Rho, {S. S.} and Kwon, {Y. G.} and H. Shim and J. Chung and Hong, {H. J.} and Song, {B. D.} and S. Lee",
year = "2013",
month = "11",
day = "28",
doi = "10.1038/onc.2013.156",
language = "English",
volume = "32",
pages = "5449--5457",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "48",

}

Ki, MK, Jeoung, MH, Choi, JR, Rho, SS, Kwon, YG, Shim, H, Chung, J, Hong, HJ, Song, BD & Lee, S 2013, 'Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro', Oncogene, vol. 32, no. 48, pp. 5449-5457. https://doi.org/10.1038/onc.2013.156

Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro. / Ki, M. K.; Jeoung, M. H.; Choi, J. R.; Rho, S. S.; Kwon, Y. G.; Shim, H.; Chung, J.; Hong, H. J.; Song, B. D.; Lee, S.

In: Oncogene, Vol. 32, No. 48, 28.11.2013, p. 5449-5457.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro

AU - Ki, M. K.

AU - Jeoung, M. H.

AU - Choi, J. R.

AU - Rho, S. S.

AU - Kwon, Y. G.

AU - Shim, H.

AU - Chung, J.

AU - Hong, H. J.

AU - Song, B. D.

AU - Lee, S.

PY - 2013/11/28

Y1 - 2013/11/28

N2 - It has been suggested that clec14a may be involved in tumor angiogenesis. However, a molecular mechanism has not been clearly identified. In this study, we show for the first time that C-type lectin-like domain (CTLD) of clec14a may be important for regulating cell migration and filopodia formation. Using phage display technology, recombinant human antibodies specific to the CTLDs of human and mouse clec14a (clec14a-CTLD (immunoglobulin G) IgG) were selected. Functional assays using the antibodies showed that clec14a-CTLD IgGs specifically blocked endothelial cell migration and tube formation without affecting cell viability or activation. Further, clec14a-CTLD IgGs inhibited clec14a-mediated cell-cell contact by blocking interaction between CTLDs. Finally, clec14a cross-linking by the clec14a-CTLD IgGs significantly downregulated clec14a expression on the surface of endothelial cells. These results strongly suggest that the clec14a-CTLD may be a key domain in angiogenesis, and that clec14a-CTLD IgGs specifically inhibit angiogenesis by modulating CTLD-mediated cell interactions and clec14a expression on the surface of endothelial cells.

AB - It has been suggested that clec14a may be involved in tumor angiogenesis. However, a molecular mechanism has not been clearly identified. In this study, we show for the first time that C-type lectin-like domain (CTLD) of clec14a may be important for regulating cell migration and filopodia formation. Using phage display technology, recombinant human antibodies specific to the CTLDs of human and mouse clec14a (clec14a-CTLD (immunoglobulin G) IgG) were selected. Functional assays using the antibodies showed that clec14a-CTLD IgGs specifically blocked endothelial cell migration and tube formation without affecting cell viability or activation. Further, clec14a-CTLD IgGs inhibited clec14a-mediated cell-cell contact by blocking interaction between CTLDs. Finally, clec14a cross-linking by the clec14a-CTLD IgGs significantly downregulated clec14a expression on the surface of endothelial cells. These results strongly suggest that the clec14a-CTLD may be a key domain in angiogenesis, and that clec14a-CTLD IgGs specifically inhibit angiogenesis by modulating CTLD-mediated cell interactions and clec14a expression on the surface of endothelial cells.

UR - http://www.scopus.com/inward/record.url?scp=84889083761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889083761&partnerID=8YFLogxK

U2 - 10.1038/onc.2013.156

DO - 10.1038/onc.2013.156

M3 - Article

C2 - 23644659

AN - SCOPUS:84889083761

VL - 32

SP - 5449

EP - 5457

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 48

ER -